Human Papilloma Virus DNA and p53 Mutation Analysis on Bladder Washes in Relation to Clinical Outcome of Bladder Cancer

European Urology

Volumn 52, Issue 2, 2007, Pages 464-469

  Moonen, Paula M J ^a   Bakkers, Judith M J E ^a   Kiemeney, Lambertus A L M ^a   Schalken, Jack A ^a   Melchers, Willem J G ^a   Witjes, J Alfred ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; Human papilloma virus; p53

Indexed keywords

PROTEIN P53; VIRUS DNA;

ARTICLE; BLADDER CANCER; BLADDER IRRIGATION; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GENOTYPE; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MUTATION; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; RISK; TREATMENT OUTCOME; VERRUCA VULGARIS; VIRUS DETECTION; WART VIRUS; WILD TYPE;

DNA MUTATIONAL ANALYSIS; DNA, VIRAL; GENES, P53; GENOTYPE; HUMANS; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; URINARY BLADDER NEOPLASMS;

EID: 34250745264     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.11.017     Document Type: Article

References (18)

1. Malats N., Bustos A., Nascimento C.M., et al. p53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol 6 (2005) 678-686
2. Smith N.D., Rubenstein J.N., Eggener S.E., and Kozlowski J.M. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol 169 (2003) 1219-1228
3. Schmitz-Drager B.J., Goebell P.J., Ebert T., and Fradet Y. p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?. Eur Urol 38 (2000) 691-699
4. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1288 (1996) F55-F78
5. Jacobs M.V., Snijders P.J., van den Brule A.J., Helmerhorst T.J., Meijer C.J., and Walboomers J.M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35 (1997) 791-795
6. Van R.M., Kaplan J.B., and Burk R.D. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 73 pt 10 (1992) 2653-2660
7. Kleiman H., and Lancaster Y. Condyloma acuminata of the bladder. J Urol 88 (1962) 52-55
8. Bryant P., Skelly J., and Wilson D. Demonstration of papillomavirus structural antigen in human urinary bladder neoplasia. Br J Urol 60 (1987) 405-409
9. Anwar K., Naiki H., Nakakuki K., and Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70 (1992) 1967-1973
10. Rotola A., Monini P., Di Luca D., et al. Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer 52 (1992) 359-365
11. Kamel D., Paakko P., Pollanen R., Vahakangas K., Lehto V.P., and Soini Y. Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS 103 (1995) 331-338
12. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990) 1129-1136
13. van Bokhoven A., Varella-Garcia M., Korch C., Hessels D., and Miller G.J. Widely used prostate carcinoma cell lines share common origins. Prostate 47 (2001) 36-51
14. van Ham M.A., Bakkers J.M., Harbers G.K., Quint W.G., Massuger L.F., and Melchers W.J. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 43 (2005) 2662-2667
15. Lopez-Beltran A., and Escudero A.L. Human papillomavirus and bladder cancer. Biomed Pharmacother 51 (1997) 252-257
16. Tenti P., Zappatore R., Romagnoli S., et al. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol 178 (1996) 65-70
17. Lopez-Beltran A., Escudero A.L., Vicioso L., Munoz E., and Carrasco J.C. Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer 73 (1996) 124-127
18. Furihata M., Inoue K., Ohtsuki Y., Hashimoto H., Terao N., and Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 53 (1993) 4823-4827